Furthermore, studies in β-catenin transgenic mouse models, targeted disruption of the Iqgap2 gene in mice, which is associated with Iqgap1 overexpression and the activation of β-catenin and cyclin D1, lead to the development of HCC. This evidence concerns the gene IQGAP1 and hepatocellular carcinoma.